RAYMOND JAMES TRUST N.A. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$23,822
+76745.2%
17,0160.0%0.00%0.0%
Q2 2023$31
-24.4%
17,0160.0%0.00%0.0%
Q1 2023$41
+70.8%
17,0160.0%0.00%0.0%
Q4 2022$24
-99.9%
17,0160.0%0.00%0.0%
Q3 2022$38,000
+8.6%
17,0160.0%0.00%0.0%
Q2 2022$35,000
-28.6%
17,0160.0%0.00%
-50.0%
Q1 2022$49,000
-10.9%
17,0160.0%0.00%0.0%
Q4 2021$55,000
-8.3%
17,0160.0%0.00%0.0%
Q3 2021$60,000
+11.1%
17,0160.0%0.00%0.0%
Q2 2021$54,000
-8.5%
17,0160.0%0.00%0.0%
Q1 2021$59,000
+37.2%
17,0160.0%0.00%0.0%
Q4 2020$43,000
+19.4%
17,0160.0%0.00%0.0%
Q3 2020$36,000
-5.3%
17,0160.0%0.00%0.0%
Q2 2020$38,000
-11.6%
17,0160.0%0.00%
-33.3%
Q1 2020$43,000
-29.5%
17,016
-26.4%
0.00%0.0%
Q4 2019$61,000
-26.5%
23,1130.0%0.00%
-25.0%
Q3 2019$83,000
+6.4%
23,1130.0%0.00%0.0%
Q2 2019$78,000
-4.9%
23,113
-23.0%
0.00%
-20.0%
Q1 2019$82,000
-1.2%
30,0000.0%0.01%0.0%
Q4 2018$83,000
-33.1%
30,0000.0%0.01%
-28.6%
Q3 2018$124,000
-20.5%
30,0000.0%0.01%
-22.2%
Q2 2018$156,000
-4.9%
30,0000.0%0.01%
-18.2%
Q1 2018$164,000
-33.1%
30,0000.0%0.01%
-31.2%
Q4 2017$245,000
-22.0%
30,0000.0%0.02%
-27.3%
Q3 2017$314,000
-5.1%
30,0000.0%0.02%
-12.0%
Q2 2017$331,000
+13.0%
30,000
-14.3%
0.02%
+13.6%
Q1 2017$293,000
+20.6%
35,0000.0%0.02%
+15.8%
Q4 2016$243,000
+19.1%
35,000
-12.5%
0.02%
+5.6%
Q3 2016$204,000
-23.3%
40,000
-10.1%
0.02%
-21.7%
Q2 2016$266,00044,5000.02%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Evermore Global Advisors, LLC 3,312,792$22,991,0004.49%
First Light Asset Management, LLC 1,007,357$6,991,0003.07%
KOPP INVESTMENT ADVISORS LLC 211,974$1,471,0001.55%
GLOBEFLEX CAPITAL L P 223,931$1,554,0000.39%
Nine Chapters Capital Management LLC 30,900$214,0000.36%
KEMPNER CAPITAL MANAGEMENT INC. 70,001$486,0000.35%
Campbell & CO Investment Adviser LLC 11,513$80,0000.25%
EAM Investors, LLC 259,914$1,804,0000.24%
Teza Capital Management LLC 14,636$102,0000.14%
Acrospire Investment Management LLC 46,220$321,0000.13%
View complete list of ENZO BIOCHEM INC shareholders